Search results
Results From The WOW.Com Content Network
Feet of a baby born to a mother who had taken thalidomide while pregnant. In the late 1950s and early 1960s, the use of thalidomide in 46 countries was prescribed to women who were pregnant or who subsequently became pregnant, and consequently resulted in the "biggest anthropogenic medical disaster ever," with more than 10,000 children born with a range of severe deformities, such as ...
Thalidomide is a known human teratogen and carries an extremely high risk of severe, life-threatening birth defects if administered or taken during pregnancy. [6] It causes skeletal deformities such as amelia (absence of legs and/or arms), absence of bones, and phocomelia (malformation of the limbs).
TIL that Thalidomide, the drug responsible for thousands of birth defects across Europe in the 1950s/60s, was developed by a doctor who had previously worked for the Nazis, experimenting on ...
DES gained notoriety when it was shown to cause a rare vaginal tumor in girls and young women who had been exposed to this drug in utero.In 1971, the New England Journal of Medicine published a report showing that seven of eight girls and young women (ages 14 to 22) who had been diagnosed with vaginal clear cell adenocarcinoma had been exposed prenatally to DES. [5]
Hagens Berman Adds Five Cases to Thalidomide Litigation Firm now represents 49 alleged victims in case against drug manufacturer, others, citing new evidence SEATTLE--(BUSINESS WIRE)-- Hagens ...
Thalidomide was eventually found to cause miscarriages, severe birth defects in babies whose mothers had taken the medication while pregnant, and severe nerve damage. [1] [failed verification] [2] In January 1968, Mückter was put on trial along with other Grünenthal employees. The trial ended abruptly in April 1970 with a settlement ...
In 1950, to conduct a simulation of a biological warfare attack, the U.S. Navy sprayed large quantities of the bacterium Serratia marcescens – considered harmless at the time – over the city of San Francisco during a project called Operation Sea-Spray. Numerous citizens contracted pneumonia-like illnesses, and at least one person died as a ...
Frances Kathleen Oldham Kelsey CM (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American [1] pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. [2]